Oncology Market Access at Risk: Is a Carrot for MDs a Stick for Pharma Companies
When Considering a Merger, Ask Why
Building the Fundamentals: Why Bold Sales Incentive Schemes Need Efficient Administration
Why Medtech's Commercial Models Must Adapt to Local Needs
Allergan Case Study: A Smart Response to Growth
Biopharma Companies Identify Biggest Challenges and Opportunities in Targeting and Activity Planning
Medtech organizations are poised on the edge of analytics-driven transformation. The number of data sources available to medtech organizations has increased exponentially over the last few years, creating options, questions and confusion. How can you sort through these options to determine which data you should pursue? And once you find it, how do you assess whether it’s worth the investment?
Read MoreTopics: data analytics, data acquisition, data acquisition strategy, Analytics, medtech, competitive advantage, commercial strategy, data overload, data investment
Medtech organizations are poised on the edge of analytics-driven transformation. The number of data sources available to medtech organizations has increased exponentially over the last few years, creating options, questions and confusion. How can you sort through these options to determine which data you should pursue? And once you find it, how do you assess whether it’s worth the investment?
View All ZS Offices
